MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$83,800K Marketable securities$17,336K Prepaid expenses andother current assets$6,359K Restricted cash$4,195K Property and equipment,at cost$82,819K Goodwill$140,627K Total current assets$111,690K Intangible asset$59,195K Operating leaseright-of-use assets$35,845K Property and equipment,net$25,673K Other non-currentassets$563K Less accumulateddepreciation$57,146K Total assets$373,593K Total liabilities andstockholders' equity$373,593K Total liabilities$254,353K Total stockholders'equity$119,240K Accumulated deficit-$1,896,226K Accumulated othercomprehensive income (loss)-$2K Total currentliabilities$86,265K Contingent consideration,net of current...$80,907K Operating leaseliabilities, net of current...$60,450K Success paymentliabilities$16,926K Other non-currentliabilities$9,805K Additional paid-in capital$2,015,441K Common stock, 0.0001par value 750,000...$27K Contingent consideration$53,556K Operating leaseliabilities$14,878K Accrued expenses andother current...$8,124K Accrued compensation$7,584K Accounts payable$2,123K
Balance Sheet

Sana Biotechnology, Inc. (SANA)

Sana Biotechnology, Inc. (SANA)

source: myfinsight.com